Sudden deafness
Sudden deafness is also called idiopathic deafness or sudden deafness. It means that tinnitus and deafness occur suddenly and instantly without tinnitus and deafness, and hearing loss reaches a peak within a few hours or days. It usually affects one ear, with a high incidence in adults aged 40 to 60. Bilateral patients account for 1%, and are more common in men. It is more likely to occur in spring and autumn. According to statistics from Byl (1977), the incidence rate is 10.7/100,000. According to statistics from the hearing clinic of Beijing Tongren Hospital, it accounts for 4.8% of the first-time sensorineural hearing loss. According to recent domestic and foreign literature reports, this disease seems to be gradually increasing.
Related Drugs
Puerarin
Indication: Used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:
Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.
Puerarin
Indication: Used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:
Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.
Nimodipine
Indication: This product is used to prevent and treat ischemic nerve damage caused by cerebral vasospasm after subarachnoid hemorrhage, as well as senile brain function damage, migraine, sudden deafness, etc.
Manufacturer:
Xi'an Bo'ai Pharmaceutical Co., Ltd.
Puerarin Sodium Chloride Injection
Indication: Used for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:
Qingdao Jinfeng Pharmaceutical Co., Ltd.
Nimodipine Capsules
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:
Suzhou No.3 Pharmaceutical Factory Co., Ltd.
Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.
Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:
Hubei Sihuan Pharmaceutical Co., Ltd.
Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:
Heilongjia PROVINCE Dina Pharmacy Co., Ltd.
Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:
Xi'an Bo'ai Pharmaceutical Co., Ltd.
Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.